newsfilter
← Latest News
GlobeNewswire·

Shareholders who lost money in shares of agilon health, inc. (NYSE: AGL) Should Contact Wolf Haldenstein Immediately

  • A federal securities class action has been filed by Wolf Haldenstein Adler Freeman & Herz LLP regarding Agilon Health, Inc. (NYSE: AGL).
  • The Class Period covers purchases of Agilon stock between February 6, 2025, and August 4, 2025.
  • The complaint alleges securities fraud and unlawful business practices by Agilon, its officers, and/or directors.
  • Triggering events on August 4, 2025, included the resignation of CEO Steven Sell, the release of Q2 2025 financial results, and the suspension of full-year 2025 financial guidance.
  • Following the announcements, Agilon's stock price dropped $0.94 per share (51.52%) to close at $0.88 on August 5, 2025.
  • Investors have until March 2, 2026, to seek appointment as lead plaintiff.
  • The law firm encourages affected investors to contact them via phone, email, or their website to join the case or provide information.